MTOR and pachyonychia congenita: The second proposed mechanism involves the phosphoinositide 3 kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR) signaling pathway, which is related to the survival and chemoresistance of PC cells.